We are live on ! Find out more
ATHN

Athenahealth, Inc.
ATHN

Delisted

ATHN was delisted on the 11th of February, 2019.

0 hedge funds and large institutions have $0 invested in Athenahealth, Inc. in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 261 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 2630 (-263)

100% less funds holding in top 10

Funds holding in top 10: 190 (-19)

100% less capital invested

Capital invested by funds: $5.08B → $0 (-$5.08B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 261

Holders
Holders Change
-263
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-19
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
261
Calls
Puts
Net Calls
Net Calls Change

ATHN Hedge Fund Activity: Q1 2019 in Review

0 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Athenahealth, Inc. (ATHN) for Q1 2019, worth a combined $0 — down 100% from $5.08B a quarter earlier.

Sellers outnumbered buyers: 261 funds closed out of ATHN and 0 opened new positions — a net loss of 261 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Morgan Stanley, exiting entirely with an estimated $593M sold.

  • 0 institutional investors held Athenahealth, Inc. (ATHN) as of Q1 2019, down from 263 in Q4 2018.
  • Funds reported $0 of Athenahealth, Inc. stock for Q1 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Athenahealth, Inc. positions in Q1 2019 and 261 closed out, a net change of -261 holders.
  • The largest Athenahealth, Inc. seller in Q1 2019 was Morgan Stanley, an estimated $593M sold.

Based on aggregated 13F filings for Q1 2019.